Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Siemens' shock wave therapy "approvable" in US:

This article was originally published in Clinica

Executive Summary

Siemens Medical Solutions' SONOCUR extracorporeal shock wave therapy has moved closer to the US market after the firm received an approvable letter for the system from the FDA. The SONOCUR Basic system is intended to treat patients with lateral epicondylitis, or tennis elbow. It may have potential for use in patients who have previously failed other conventional therapies, said the Iselin, New Jersey firm. Siemens' premarket approval application is supported by data from a multicentre, 114-patient US trial.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT066898

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel